Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.
Identifieur interne : 003907 ( PubMed/Curation ); précédent : 003906; suivant : 003908Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.
Auteurs : Valérie Andresz [France] ; Nicolas Marcantoni ; Florence Binder ; Michel Velten ; Martine Alt ; Jean-Christophe Weber ; Dominique StephanSource :
- Addiction (Abingdon, England) [ 0965-2140 ] ; 2006.
Descripteurs français
- KwdFr :
- Antagonistes narcotiques (administration et posologie), Antagonistes narcotiques (effets indésirables), Buprénorphine (administration et posologie), Buprénorphine (effets indésirables), Facteurs de risque, Femelle, France, Humains, Lymphoedème (), Main, Mâle, Statistique non paramétrique, Syndrome, Toxicomanie intraveineuse (), Études cas-témoins.
- MESH :
- administration et posologie : Antagonistes narcotiques, Buprénorphine.
- effets indésirables : Antagonistes narcotiques, Buprénorphine.
- Facteurs de risque, Femelle, France, Humains, Lymphoedème, Main, Mâle, Statistique non paramétrique, Syndrome, Toxicomanie intraveineuse, Études cas-témoins.
- Wicri :
- geographic : France.
English descriptors
- KwdEn :
- Buprenorphine (administration & dosage), Buprenorphine (adverse effects), Case-Control Studies, Female, France, Hand, Humans, Lymphedema (chemically induced), Male, Narcotic Antagonists (administration & dosage), Narcotic Antagonists (adverse effects), Risk Factors, Statistics, Nonparametric, Substance Abuse, Intravenous (complications), Syndrome.
- MESH :
- chemical , administration & dosage : Buprenorphine, Narcotic Antagonists.
- chemical , adverse effects : Buprenorphine, Narcotic Antagonists.
- geographic : France.
- chemically induced : Lymphedema.
- complications : Substance Abuse, Intravenous.
- Case-Control Studies, Female, Hand, Humans, Male, Risk Factors, Statistics, Nonparametric, Syndrome.
Abstract
We studied the pathogenesis of puffy hand syndrome of intravenous drug use. We hypothesized that injections of high-dose sublingual buprenorphine, instead of the recommended sublingual administration, could play an important role in lymphatic obstruction and destruction.
DOI: 10.1111/j.1360-0443.2006.01521.x
PubMed: 16911735
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :003907
Links to Exploration step
pubmed:16911735Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.</title><author><name sortKey="Andresz, Valerie" sort="Andresz, Valerie" uniqKey="Andresz V" first="Valérie" last="Andresz">Valérie Andresz</name><affiliation wicri:level="1"><nlm:affiliation>Hypertension Maladies vasculaires Pharmacologie clinique, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg cedex, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hypertension Maladies vasculaires Pharmacologie clinique, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg cedex</wicri:regionArea></affiliation></author><author><name sortKey="Marcantoni, Nicolas" sort="Marcantoni, Nicolas" uniqKey="Marcantoni N" first="Nicolas" last="Marcantoni">Nicolas Marcantoni</name></author><author><name sortKey="Binder, Florence" sort="Binder, Florence" uniqKey="Binder F" first="Florence" last="Binder">Florence Binder</name></author><author><name sortKey="Velten, Michel" sort="Velten, Michel" uniqKey="Velten M" first="Michel" last="Velten">Michel Velten</name></author><author><name sortKey="Alt, Martine" sort="Alt, Martine" uniqKey="Alt M" first="Martine" last="Alt">Martine Alt</name></author><author><name sortKey="Weber, Jean Christophe" sort="Weber, Jean Christophe" uniqKey="Weber J" first="Jean-Christophe" last="Weber">Jean-Christophe Weber</name></author><author><name sortKey="Stephan, Dominique" sort="Stephan, Dominique" uniqKey="Stephan D" first="Dominique" last="Stephan">Dominique Stephan</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:16911735</idno><idno type="pmid">16911735</idno><idno type="doi">10.1111/j.1360-0443.2006.01521.x</idno><idno type="wicri:Area/PubMed/Corpus">003907</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">003907</idno><idno type="wicri:Area/PubMed/Curation">003907</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">003907</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.</title><author><name sortKey="Andresz, Valerie" sort="Andresz, Valerie" uniqKey="Andresz V" first="Valérie" last="Andresz">Valérie Andresz</name><affiliation wicri:level="1"><nlm:affiliation>Hypertension Maladies vasculaires Pharmacologie clinique, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg cedex, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Hypertension Maladies vasculaires Pharmacologie clinique, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg cedex</wicri:regionArea></affiliation></author><author><name sortKey="Marcantoni, Nicolas" sort="Marcantoni, Nicolas" uniqKey="Marcantoni N" first="Nicolas" last="Marcantoni">Nicolas Marcantoni</name></author><author><name sortKey="Binder, Florence" sort="Binder, Florence" uniqKey="Binder F" first="Florence" last="Binder">Florence Binder</name></author><author><name sortKey="Velten, Michel" sort="Velten, Michel" uniqKey="Velten M" first="Michel" last="Velten">Michel Velten</name></author><author><name sortKey="Alt, Martine" sort="Alt, Martine" uniqKey="Alt M" first="Martine" last="Alt">Martine Alt</name></author><author><name sortKey="Weber, Jean Christophe" sort="Weber, Jean Christophe" uniqKey="Weber J" first="Jean-Christophe" last="Weber">Jean-Christophe Weber</name></author><author><name sortKey="Stephan, Dominique" sort="Stephan, Dominique" uniqKey="Stephan D" first="Dominique" last="Stephan">Dominique Stephan</name></author></analytic><series><title level="j">Addiction (Abingdon, England)</title><idno type="ISSN">0965-2140</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Buprenorphine (administration & dosage)</term><term>Buprenorphine (adverse effects)</term><term>Case-Control Studies</term><term>Female</term><term>France</term><term>Hand</term><term>Humans</term><term>Lymphedema (chemically induced)</term><term>Male</term><term>Narcotic Antagonists (administration & dosage)</term><term>Narcotic Antagonists (adverse effects)</term><term>Risk Factors</term><term>Statistics, Nonparametric</term><term>Substance Abuse, Intravenous (complications)</term><term>Syndrome</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Antagonistes narcotiques (administration et posologie)</term><term>Antagonistes narcotiques (effets indésirables)</term><term>Buprénorphine (administration et posologie)</term><term>Buprénorphine (effets indésirables)</term><term>Facteurs de risque</term><term>Femelle</term><term>France</term><term>Humains</term><term>Lymphoedème ()</term><term>Main</term><term>Mâle</term><term>Statistique non paramétrique</term><term>Syndrome</term><term>Toxicomanie intraveineuse ()</term><term>Études cas-témoins</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Buprenorphine</term><term>Narcotic Antagonists</term></keywords><keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Buprenorphine</term><term>Narcotic Antagonists</term></keywords><keywords scheme="MESH" type="geographic" xml:lang="en"><term>France</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Antagonistes narcotiques</term><term>Buprénorphine</term></keywords><keywords scheme="MESH" qualifier="chemically induced" xml:lang="en"><term>Lymphedema</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Substance Abuse, Intravenous</term></keywords><keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Antagonistes narcotiques</term><term>Buprénorphine</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Case-Control Studies</term><term>Female</term><term>Hand</term><term>Humans</term><term>Male</term><term>Risk Factors</term><term>Statistics, Nonparametric</term><term>Syndrome</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Facteurs de risque</term><term>Femelle</term><term>France</term><term>Humains</term><term>Lymphoedème</term><term>Main</term><term>Mâle</term><term>Statistique non paramétrique</term><term>Syndrome</term><term>Toxicomanie intraveineuse</term><term>Études cas-témoins</term></keywords><keywords scheme="Wicri" type="geographic" xml:lang="fr"><term>France</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">We studied the pathogenesis of puffy hand syndrome of intravenous drug use. We hypothesized that injections of high-dose sublingual buprenorphine, instead of the recommended sublingual administration, could play an important role in lymphatic obstruction and destruction.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16911735</PMID><DateCreated><Year>2006</Year><Month>08</Month><Day>16</Day></DateCreated><DateCompleted><Year>2007</Year><Month>01</Month><Day>18</Day></DateCompleted><DateRevised><Year>2013</Year><Month>11</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">0965-2140</ISSN><JournalIssue CitedMedium="Print"><Volume>101</Volume><Issue>9</Issue><PubDate><Year>2006</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Addiction (Abingdon, England)</Title><ISOAbbreviation>Addiction</ISOAbbreviation></Journal><ArticleTitle>Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.</ArticleTitle><Pagination><MedlinePgn>1347-51</MedlinePgn></Pagination><Abstract><AbstractText Label="AIM" NlmCategory="OBJECTIVE">We studied the pathogenesis of puffy hand syndrome of intravenous drug use. We hypothesized that injections of high-dose sublingual buprenorphine, instead of the recommended sublingual administration, could play an important role in lymphatic obstruction and destruction.</AbstractText><AbstractText Label="DESIGN AND PARTICIPANTS" NlmCategory="METHODS">We set up a case-control study in substitution centres, recruiting intravenous drug addicts with and without puffy hands, respectively. The subjects were asked to answer anonymously a questionnaire of 40 items comprising social and demographic status, history of illicit drugs use, buprenorphine misuse and injection practices.</AbstractText><AbstractText Label="FINDINGS" NlmCategory="RESULTS">We included 33 cases and 33 controls, mean age of 34 years. They were past heroin users, mainly methadone-substituted. In multivariate analysis, sex (women) (OR = 8.9, P = 0.03), injections in the hands (OR = 5.9, P = 0.03), injections in the feet (OR = 6.5, P = 0.01) and the absence of tourniquet (OR = 7.0, p = 0.02) were significant risk factors for puffy hand syndrome. In 69.7% of the cases and 59.4% of the controls, respectively, there was a high-dose sublingual buprenorphine misuse, although it appeared not to be a significant risk factor for puffy hand syndrome.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Injection practices are likely to cause puffy hands syndrome, but buprenorphine misuse should not be considered as a significant risk factor. However, intravenous drug users must still be warned of local and systemic complications of intravenous drug misuse.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Andresz</LastName><ForeName>Valérie</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Hypertension Maladies vasculaires Pharmacologie clinique, Hôpitaux Universitaires de Strasbourg, 67091 Strasbourg cedex, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcantoni</LastName><ForeName>Nicolas</ForeName><Initials>N</Initials></Author><Author ValidYN="Y"><LastName>Binder</LastName><ForeName>Florence</ForeName><Initials>F</Initials></Author><Author ValidYN="Y"><LastName>Velten</LastName><ForeName>Michel</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Alt</LastName><ForeName>Martine</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Weber</LastName><ForeName>Jean-Christophe</ForeName><Initials>JC</Initials></Author><Author ValidYN="Y"><LastName>Stephan</LastName><ForeName>Dominique</ForeName><Initials>D</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016448">Multicenter Study</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Addiction</MedlineTA><NlmUniqueID>9304118</NlmUniqueID><ISSNLinking>0965-2140</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009292">Narcotic Antagonists</NameOfSubstance></Chemical><Chemical><RegistryNumber>40D3SCR4GZ</RegistryNumber><NameOfSubstance UI="D002047">Buprenorphine</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D002047" MajorTopicYN="N">Buprenorphine</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005602" MajorTopicYN="N" Type="Geographic">France</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006225" MajorTopicYN="N">Hand</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008209" MajorTopicYN="N">Lymphedema</DescriptorName><QualifierName UI="Q000139" MajorTopicYN="Y">chemically induced</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009292" MajorTopicYN="N">Narcotic Antagonists</DescriptorName><QualifierName UI="Q000008" MajorTopicYN="N">administration & dosage</QualifierName><QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012307" MajorTopicYN="N">Risk Factors</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018709" MajorTopicYN="N">Statistics, Nonparametric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015819" MajorTopicYN="N">Substance Abuse, Intravenous</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="Y">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013577" MajorTopicYN="N">Syndrome</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>8</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2007</Year><Month>1</Month><Day>19</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>8</Month><Day>17</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">16911735</ArticleId><ArticleId IdType="pii">ADD1521</ArticleId><ArticleId IdType="doi">10.1111/j.1360-0443.2006.01521.x</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003907 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 003907 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= PubMed
|étape= Curation
|type= RBID
|clé= pubmed:16911735
|texte= Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:16911735" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |